Show simple item record

dc.contributor.editorLópez, José I.
dc.contributor.editorManini, Claudia
dc.date.accessioned2023-04-05T13:01:26Z
dc.date.available2023-04-05T13:01:26Z
dc.date.issued2023
dc.identifierONIX_20230405_9783036569680_246
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/98967
dc.description.abstractIn the urological sphere, the number of tumor malignancies caused by cancer is continuously growing in Western countries. Although this is mainly due to the contemporary increase in the life expectancy of people in these geographic areas, many other factors are also contributing to this growth. Urological cancer is a complex and varied disease which affects different organs and mainly affects the male population. In fact, in most statistics, kidney, prostate, and bladder cancer are regularly included in the top-ten list of the most frequent neoplasms in males. The female population, however, has also been increasingly affected by renal and bladder cancer in the last decade. From these facts, it is clear that urological cancer is a problem of major concern in developed societies. This Topic Issue of Cancers intends to shed some light on the complexity of this field and will consider all useful and appropriate contributions from scientists and clinicians in order to improve urological cancer knowledge for patients’ benefit.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncologyen_US
dc.subject.otherhigh-risk prostate cancer
dc.subject.otherandrogen receptor axis
dc.subject.othercastration resistance
dc.subject.otherneuroendocrine carcinoma
dc.subject.otherPARP inhibition
dc.subject.otherimmunotherapy
dc.subject.othercancer genome
dc.subject.otherprecision targeting
dc.subject.otherrobot-assisted partial nephrectomy
dc.subject.otherrenal cell carcinoma
dc.subject.otherindocyanine green
dc.subject.othernephron sparing
dc.subject.otherprostate cancer survivors
dc.subject.otherfollow-up care
dc.subject.otherprimary health care
dc.subject.othergeneral practice
dc.subject.otherprocess evaluation
dc.subject.otherConsolidated Framework for Implementation Research
dc.subject.otherprostate-specific membrane antigen positron-emission tomography
dc.subject.othermultiparametric magnetic-resonance imaging
dc.subject.otherprimary diagnosis
dc.subject.otherprostate cancer
dc.subject.othersystematic review
dc.subject.otherdiagnosis
dc.subject.otherPSMA
dc.subject.otherPSA
dc.subject.othertumor
dc.subject.otherPET scan
dc.subject.otherbladder cancer
dc.subject.otherbisphenol A
dc.subject.otherbisphenol S
dc.subject.otherenergy metabolism
dc.subject.othermigration
dc.subject.otherproliferation
dc.subject.othercarbon-ion radiotherapy
dc.subject.otherelderly patients
dc.subject.otherradiotherapy
dc.subject.otherparticle beam therapy
dc.subject.otherlife expectancy
dc.subject.othersystemic immune-inflammation index
dc.subject.otherCharlson comorbidity index
dc.subject.otherCAPRA-S
dc.subject.otherearly survival
dc.subject.othermale incontinence
dc.subject.otherrobotic prostatectomy
dc.subject.otherclear cell renal cell carcinoma
dc.subject.otherferroptosis
dc.subject.otherprognostic model
dc.subject.otherTCGA
dc.subject.otherE-MTAB-1980
dc.subject.otherGLS2
dc.subject.otherpazopanib
dc.subject.otherreal-world data
dc.subject.othernon-interventional study
dc.subject.othertime on drug
dc.subject.othernivolumab
dc.subject.othereverolimus
dc.subject.othertrial-eligibility
dc.subject.otherureteral neoplasms
dc.subject.otherurinary bladder neoplasms
dc.subject.otherureteroscopy
dc.subject.otherCNTF
dc.subject.otherCNTFRα
dc.subject.otherLNCaP
dc.subject.other22Rv1
dc.subject.othercastration resistant
dc.subject.othercastration sensitive
dc.subject.otherSTAT3
dc.subject.otherERK
dc.subject.otherMMP
dc.subject.otherbiomarker
dc.subject.otherGleason grade
dc.subject.othertransforming growth factor-β family
dc.subject.otheractivin
dc.subject.otherINHBA
dc.subject.otherINHBB
dc.subject.otherINHBC
dc.subject.otherprostate-specific antigen
dc.subject.otherfalse-positive results
dc.subject.otherreal world-data
dc.subject.othern/a
dc.titleUrological Cancer 2022
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-6969-7
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036569680
oapen.relation.isbn9783036569697
oapen.pages238
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/